Background and Purpose The systemic immune-inflammation index, a new index based on
platelets, neutrophils and lymphocytes, has been shown to be associated with outcomes of …

Objective To describe and analyze the predictive models of the prognosis of patients with
hepatocellular carcinoma (HCC) undergoing systemic treatment. Design Systematic review …

Background At present, hepatectomy is still the most common and effective treatment
method for intrahepatic cholangiocarcinoma (ICC) patients. However, the postoperative …

Introduction Sorafenib is currently the first-line therapeutic regimen for patients with
advanced hepatocellular carcinoma (HCC). However, many patients did not experience any …

Background The combination of immune checkpoint inhibitors (ICIs) and anti-angiogenic
agents has shown promising efficacy in unresectable hepatocellular carcinoma (HCC), but …

Aberrant expression of members of the proteasome subunit beta (PSMB) family (including
PSMB2, PSMB4, PSMB7 and PSMB8) has been reported in hepatocellular carcinoma …

Background The prognosis for patients diagnosed of hepatocellular carcinoma (HCC) who
have extrahepatic metastasis after liver resection is unsatisfactory. This study aimed to find …

Aim: To show the prognostic significance of the glucose-to-lymphocyte ratio (GLR) in
hepatocellular carcinoma (HCC). Patients & methods: A total of 150 patients with advanced …

Background Hepatocellular carcinoma (HCC) has high incidence and mortality worldwide.
Local ablation using radiofrequency ablation (RFA) or microwave ablation (MWA) is …

Albumin to gamma‐glutamyltransferase ratio (AGR) is a newly developed biomarker for the
prediction of patients' prognosis in solid tumors. The purpose of the study was to establish a …